sahin.io

News

Aether
BiotechSeries A

Raised $15M to reindustrialize America with AI-designed proteins

Company Context

Company Value
$110M
Revenue
Estimated $10M-$25M (Source: LeadIQ)
Market
Biotech
Stage
Series A
Key Highlight

Aether Biomachines raised $15M in December 2025 to scale its AI-designed protein manufacturing.

More from Aether

More Biotech News